Selectis Health (GBCS) Net Cash Flow (2010 - 2025)

Selectis Health has disclosed Net Cash Flow across 16 years of filings, most recently posting $629682.0 for Q4 2025.

• Net Cash Flow for Q4 2025 came in at $629682.0, up 246.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $461727.0 (up 150.59% YoY), and the FY2025 annual result was $461727.0, up 150.59% from the prior year.
• Net Cash Flow came in at $629682.0 for Q4 2025 at Selectis Health, up from -$107912.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.0 million in Q2 2024 to a low of -$2.2 million in Q3 2024.
• The 5-year median for Net Cash Flow is -$202716.0 (2021), against an average of -$106230.5.
• Peak annual rise in Net Cash Flow reached 758.31% in 2022, while the deepest fall reached 1462.34% in 2022.
• Selectis Health's Net Cash Flow stood at $1.2 million in 2021, then slumped by 129.13% to -$343559.0 in 2022, then tumbled by 123.15% to -$766656.0 in 2023, then soared by 43.83% to -$430630.0 in 2024, then surged by 246.22% to $629682.0 in 2025.
• The last three Net Cash Flow figures came in at $629682.0 (Q4 2025), -$107912.0 (Q3 2025), and -$693775.0 (Q2 2025), per Business Quant data.